Key Takeaways:
- Perfuze is an Irish medtech startup focussed on developing innovative treatment for acute ischemic stroke.
- Founded by Wayne Allen and Liam Mullins, Perfuze’s technology aims to provide superior clinical outcomes and shorter procedural times, making therapy safer and more cost-effective.
- The company is based out of National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park, Dangan, Galway.
Medical technology is witnessing continual advancements that are revolutionising the way diseases are diagnosed and treated. One such startup contributing to this revolution is Perfuze, based in Galway, Ireland. Founded in 2018 by Wayne Allen and Liam Mullins, who collectively bring over 30 years of medtech experience, Perfuze is disrupting the field with its innovative approach to treating acute ischemic stroke.
Perfuze is crafting excellence in the field of medicine with their innovative catheter technology. Aiming to offer superior clinical outcomes in shorter procedural times, this technology is designed to provide safe and cost-effective therapy, answering the lingering question – Can new medical tech result in superior clinical outcomes?
What truly distinguishes Perfuze in the world of medical tech startups is their hyper-focused approach to stroke treatment. While many other players are spreading their energies across multiple disease areas, Perfuze is committed to pushing the boundaries of technology to improve the outcomes specifically for patients suffering from acute ischemic stroke.
Their cutting-edge catheter technology, still in the research and development phase, is poised to transform stroke therapy. Its innovation lies in its attempt to deliver more rapid and effective treatment that can reduce patient recovery times while ensuring the therapy remains cost-effective for healthcare providers.
Looking towards the future, Perfuze is on a clear trajectory of growth. The company’s relocation to the IDA Business Park in Dangan, Galway, will provide the room they need to scale their operations. With the understanding that medical technology evolves in response to increasing healthcare demands and advancing scientific understanding, the future of stroke treatment and healthcare certainly looks promising.
What is evident is that Perfuze is not just about the bottom line – the team truly cares about making a difference in the lives of stroke patients. And with that vision firmly in view, the founders and their team are undoubtedly set to leave a substantial imprint on the medtech landscape. You can follow their journey and innovations on their website and LinkedIn page linked below.
“`
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
